Evaluation in STEMI Patients Using FDY-5301
NCT04837001
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2351
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Myocardial Infarction
STEMI
Percutaneous Coronary Revascularization
Interventions
DRUG:
FDY-5301
OTHER:
Placebo
Sponsor
Faraday Pharmaceuticals, Inc.